Clinical Trial Update: Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating accelerated opiate detoxification and naltrexone induction using buprenorphine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders

Drugs mentioned

• Naltrexone (Naltrexone)
• buprenorphine (buprenorphine)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Opioid-Related Disorders | Phase 2 | Status: COMPLETED